IREN Stock Surges After 16 Billion Dell Deal to Accelerate AI Infrastructure Buildout Global Shares Rise Oil Prices Drop as Trump Indicates Progress in War Talks Analyst Report Highlights TJX Companies Market Position and Growth Potential Puig Shares Plunge as Este Lauder TieUp Talks Collapse European Markets Edge Higher SpaceXs AI Compute Deal with Anthropic May End Sooner Than Anticipated Musk Says Wells Fargo Settles Discrimination Lawsuit with 100M Borrower Assistance Program Across 51 Cities FuelCell Energy Q1 2026 Earnings EPS Surpasses Estimates Amid Ongoing Operational Challenges AREB Q1 2026 Earnings Deep Losses Reported Stock Surges Over 22 TDG Q1 2026 Earnings EPS Surpasses Estimates on Robust Aerospace Demand BOLT Q1 2026 Earnings EPS Misses Estimates on Higher RD Costs Stock Edges Up DQ Q1 2026 Earnings Polysilicon Market Headwinds Lead to Substantial EPS Miss BBNX Q1 2026 Earnings Narrow Beat on EPS Amid Limited Revenue Disclosure Logitech LOGI Slips Slightly Support Test Looms Near 10475 Columbus Acquisition Corp Rights COLAR Surge 1176 Whats Driving the Recent Rally PagerDuty Inc PD Rallies 327 as Stock Nears Key Resistance Level Vendome Acquisition Corporation I VNME Holds Steady at 1017 SPAC Stability in Focus Wheeler Real Estate Investment Trust WHLR Plunges 116 as Bearish Sentiment Builds Bharti Airtel Expands International Footprint with Increased Stakes in Africa and UKs BT Aspen Aerogels Inc ASPN Q1 2026 Earnings EPS Misses Estimates Stock Rises on Optimism Encore Capital Group ECPG Slips 168 as Shares Test Key Support at 80 EXG Edges Higher Eaton Vance Global Equity Income Fund Gains 09 Amid Steady Trading Somnigroup International SGI Edges Lower in Quiet Session Consolidation Between Key Levels Delek US Holdings DK Rallies Nearly 3 Tests Key Resistance Near 4551 MarketAxess Holdings MKTX Holds Steady Near Key Support as RangeBound Trading Continues Indigo Acquisition Corp Unit INACU Holds Steady Near 1028 as SPAC Market Digests Recent Catalysts Soren Acquisition Corp SORN Holds Steady at 992 Consolidation Phase Ahead Inhibrx Biosciences INBX Surges Over 5 as Biotech Momentum Builds